Welgene Biotech Co., Ltd. (6661) Stock Price & Analysis
6661 Stock Chart & Stats
- Day’s Range
- TWD 15.05 - TWD 16.20
- 52-Week Range
- TWD 15.05 - TWD 20.35
- Previous Close
- TWD 15.55
- Volume
- N/A
- Average Volume (3M)
- 3,579
- Market Cap
- TWD 376.36M
- Enterprise Value
- TWD 503.13M
- Total Cash (Recent Filing)
- TWD 201.99M
- Total Debt (Recent Filing)
- TWD 281.15M
- Price to Earnings (P/E)
- ―
- Beta
- 0.27
- Next Earnings
- Nov 17, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Mar 16, 2023
- Dividend Yield
- N/A
6661 FAQ
What was Welgene Biotech Co., Ltd.’s price range in the past 12 months?
What is Welgene Biotech Co., Ltd.’s market cap?
When is Welgene Biotech Co., Ltd.’s upcoming earnings report date?
How were Welgene Biotech Co., Ltd.’s earnings last quarter?
Is Welgene Biotech Co., Ltd. overvalued?
Does Welgene Biotech Co., Ltd. pay dividends?
What is Welgene Biotech Co., Ltd.’s EPS estimate?
How many shares outstanding does Welgene Biotech Co., Ltd. have?
What happened to Welgene Biotech Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Welgene Biotech Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Welgene Biotech Co., Ltd.
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
- Sector
- General
- Industry
- Medical - Diagnostics & Research
- CEO
- Yi Xing Lin
- Employees
- 80
- Website
- www.welgene.com.tw
- Address
- No. 3, Yuanyuan Street, Taipei, TP, 11503, TW
Welgene Biotech Co., Ltd. (6661) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 2 | 12 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 2 | 0 | 10 |

